Abstract

Most metabolic studies on mice are performed at room temperature, although under these conditions mice, unlike humans, spend considerable energy to maintain core temperature. Here, we characterize the impact of housing temperature on energy expenditure (EE), energy homeostasis and plasma concentrations of appetite- and glucoregulatory hormones in normal-weight and diet-induced obese (DIO) C57BL/6J mice fed chow or 45% high-fat-diet, respectively. Mice were housed for 33 days at 22, 25, 27.5, and 30 °C in an indirect-calorimetry-system. We show that energy expenditure increases linearly from 30 °C towards 22 °C and is ~30% higher at 22 °C in both mouse models. In normal-weight mice, food intake counter-balances EE. In contrast, DIO mice do not reduce food intake when EE is lowered. By end of study, mice at 30 °C, therefore, had higher body weight, fat mass and plasma glycerol and triglycerides than mice at 22 °C. Dysregulated counterbalancing in DIO mice may result from increased pleasure-based eating.

The impact of ambient housing temperature on the interaction of energy intake, energy expenditure and glycemic control in normal and diet-induced obese mice is examined.

Details

Title
Housing-temperature reveals energy intake counter-balances energy expenditure in normal-weight, but not diet-induced obese, male mice
Author
John, Linu Mary 1 ; Petersen, Natalia 1 ; Gerstenberg, Marina Kjærgaard 1 ; Torz, Lola 2   VIAFID ORCID Logo  ; Pedersen, Kent 1 ; Christoffersen, Berit Østergaard 1 ; Kuhre, Rune Ehrenreich 3   VIAFID ORCID Logo 

 Novo Nordisk A/S, Global Obesity and Liver Disease, Global Drug Discovery, Måløv, Denmark (GRID:grid.425956.9) (ISNI:0000 0004 0391 2646) 
 Novo Nordisk A/S, Global Obesity and Liver Disease, Global Drug Discovery, Måløv, Denmark (GRID:grid.425956.9) (ISNI:0000 0004 0391 2646); University of Copenhagen, Department of Veterinary and Animal Science, Faculty of Health and Medical Sciences, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
 Novo Nordisk A/S, Global Obesity and Liver Disease, Global Drug Discovery, Måløv, Denmark (GRID:grid.425956.9) (ISNI:0000 0004 0391 2646); University of Copenhagen, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, DK-2200, Copenhagen, Denmark (GRID:grid.5254.6) (ISNI:0000 0001 0674 042X) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2712352873
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.